Semaglutide in NASH-related cirrhosis: too late to the party?
- PMID: 36934739
- DOI: 10.1016/S2468-1253(23)00069-9
Semaglutide in NASH-related cirrhosis: too late to the party?
Conflict of interest statement
I declare no competing interests.
Comment on
-
Semaglutide 2·4 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial.Lancet Gastroenterol Hepatol. 2023 Jun;8(6):511-522. doi: 10.1016/S2468-1253(23)00068-7. Epub 2023 Mar 16. Lancet Gastroenterol Hepatol. 2023. PMID: 36934740 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
